BFM
CLDI.WS

Boothbay Fund Management’s Calidi Biotherapeutics, Inc. Redeemable Warrants, each whole warrant exercisable for 1/10th of a share of Common Stock at an exercise price of $115.00 CLDI.WS Stock Holding History

Boothbay Fund Management’s Portfolio CLDI.WS Stock Details CLDI.WS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-22,626
Closed -$223K – 2217
2022
Q3 		$223K Hold
22,626
– – 0.01% 1487
2022
Q2 		$225K Hold
22,626
– – 0.01% 1424
2022
Q1 		$224K Hold
22,626
– – 0.01% 1441
2021
Q4 		$222K Buy
+22,626
New +$222K 0.01% 1272